Advertisement
Advertisement

JAGX

JAGX logo

Jaguar Health, Inc.

3.00
USD
Sponsored
+0.02
+0.67%
May 08, 15:56 UTC -4
Closed
exchange

After-Market

3.01

+0.01
+0.33%

Jaguar Health, Inc. Profile

About

Jaguar Health, Inc. is a natural-products pharmaceuticals company. It focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals. The company through its subsidiary Napo Pharmaceuticals Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals. Its product pipeline consists of Mytesi(R), Canalevia(TM), Equilevia(TM) and Neonorm (TM). Jaguar Health Inc., formerly known as Jaguar Animal Health Inc., is based in San Francisco, United States.

Info & Links

CEO

Lisa A. Conte

Headquarters

200 PINE STREET SUITE 400
SAN FRANCISCO, CA 94104, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

https://jaguar.health

Auditor

RBSM LLP

Share holders

9

Employees

49

Jaguar Health, Inc. Statistics

Valuation Measures

Market Capitalization2

1.12M

Enterprise Value

35.81M

Enterprise Value/EBITDA(ttm)

-0.82

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.12

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

68.45%

Operating Margin(ttm)

-344.57%

Profit Margin(ttm)

-461.85%

Return on Equity(ttm)

-1194.94%

Return on Invested Capital(ttm)

448.06%

Return on Assets(ttm)

-80.16%

Income Statement

Revenue(ttm)

11.51M

Revenue Per Share(ttm)

0.88

Gross Profit(ttm)

7.74M

EBITDA(ttm)3

-43.55M

Net Income Available to Common(ttm)

-53.58M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.27

52-Week Change

-98.92%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

13.02M

Dividend Yield

0.00%

Float4

3.46M

% Held by Insiders

7.46%

% Held by Institutions

12.04%

Balance Sheet

Total Cash(mrq)

7.83M

Total Cash Per Share(mrq)

0.60

Total Debt(mrq)

42.52M

Total Debt/Equity(mrq)

-227.54%

Current Ratio(mrq)

0.50%

Quick Ratio(mrq)

0.52%

Book Value Per Share(mrq)

-2.68

Cash Flow

Operating Cash Flow Per Share(ytd)

-10.16

Free Cash Flow(ytd)

-23.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement